Deliver to
United Kingdom
Order number: 35CX.1
Part number: AC100008067
Recommended for applications requiring controlled solvent behavior, the Hplc Column Nucleodur® C 18 Gravity, 3 μm, 150 mm, 2 mm offers exceptional performance for reversed phase separations. Its high density C 18 phase based on high purity NUCLEODUR® silica gel ensures suppression of unwanted polar interactions, making it ideal for the separation of basic and other ionizable analytes. With enhanced pH stability, LC/MS suitability, and superior base deactivation, this column is an excellent choice for method development and valuable for RP applications. It is particularly suited for compounds with ionizable functional groups such as basic pharmaceuticals and pesticides, including analgesics, antidepressants, anti-inflammatory drugs, herbicides, immunosuppressants, pharmaceutical products, phytopharm
| Name | Value | |
|---|---|---|
| Phase | : | C 18 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L1 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 0.45 ml |
| Particle size | : | 3 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 150 x 2 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
| Application Database (Macherey-Nagel) | : | HPLC SPE |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.
